33 employees
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.
2020
$25M
from 2 investors over 2 rounds
Magnus Medical raised $25M on October 28, 2021
Investors: JAZZ Venture Partners and Red Tree Venture Capital